Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

News Brief

Summary

Oddity, the parent company of Il Makiage, has launched a new telehealth skincare brand called Methodiq. This platform offers 28 prescription and over-the-counter products targeting acne, eczema, and hyperpigmentation, priced between $29 and $59. The move positions Oddity to compete with companies like Hims & Hers in the growing medical skincare market and signals a potential deeper expansion into healthcare.

Key Points

  • New Brand Launch: Oddity launched Methodiq, a telehealth platform for medical-grade skincare.
  • Product Range: Offers 28 products (creams, supplements, cosmetics) for conditions like acne and eczema, priced ~$29-$59.
  • Strategic Aim: Directly competes with telehealth platform Hims & Hers and taps into a market projected to reach $113 billion this year.
  • Technology Core: Leverages AI, computational imaging (from acquisition Voyage81), and biotechnology (from Oddity Labs) for diagnosis and product formulation.
  • User Process: Users complete an online consultation and facial scan; a U.S.-based doctor reviews the information and prescribes a personalized product “kit.”
  • Market Opportunity: Addresses the lack of dermatologist access in over 60% of U.S. counties.
  • Future Potential: Oddity sees “enormous revenue potential” and may expand into other medical domains beyond dermatology.
  • Challenges: The sector is highly regulated, competitive, and requires building customer trust in telehealth safety and scalability.

新闻简报

总结

Il Makiage 的母公司 Oddity 推出了一个新的远程医疗护肤品牌 Methodiq。该平台提供28种针对痤疮、湿疹和色素沉着过度的处方药和非处方产品,价格在29至59美元之间。此举使 Oddity 能够与 Hims & Hers 等公司在不断增长的医疗护肤市场竞争,并标志着其可能向医疗保健领域进行更深入的扩张。

关键点

  • 新品牌发布: Oddity 推出了 Methodiq,一个用于医疗级护肤的远程医疗平台。
  • 产品范围: 提供28种产品(面霜、补充剂、化妆品),针对痤疮、湿疹等皮肤问题,价格约29-59美元。
  • 战略目标: 直接与远程医疗平台 Hims & Hers 竞争,并进入一个预计今年将达到1130亿美元的市场。
  • 技术核心: 利用人工智能、计算成像(来自收购的 Voyage81)和生物技术(来自 Oddity Labs)进行诊断和产品配方。
  • 用户流程: 用户完成在线咨询和面部扫描;一位在美国的医生审核信息并开具个性化的产品”套盒”。
  • 市场机遇: 解决了美国超过60%的县没有皮肤科医生的问题。
  • 未来潜力: Oddity 认为该品牌具有”巨大的未来收入潜力”,并可能扩展到皮肤科以外的其他医疗领域。
  • 面临挑战: 该行业监管严格、竞争激烈,并且需要在远程医疗的安全性和可扩展性方面建立客户信任。

Original Article Link: https://www.cnbc.com/2025/11/18/oddity-launches-telehealth-skincare-platform-methodiq.html

Scroll to Top